Last reviewed · How we verify

NCT06907303: RNA-EndoDx

RNA Assays for Endometriosis Detection and Diagnosis

ENROLLING BY INVITATION Last updated 2 April 2025
What this trial tests

trial testing EndoDx in Endometriosis in 400 participants. Enrolling by invitation.

Timeline
1 January 2024
Primary endpoint
31 August 2025
31 December 2026

Quick facts

Lead sponsorWren Laboratories LLC
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment400
Start date1 January 2024
Primary completion31 August 2025
Estimated completion31 December 2026
Sites2 locations across South Africa, United States

Drugs / interventions tested

Conditions studied

Sponsor

Wren Laboratories LLC — full company profile →

Who can join

Adults 20 to 35, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Wren Laboratories LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06907303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing